Tandem Diabetes Care, Inc. (TNDM) Return on equity 2018–2025
Tandem Diabetes Care, Inc. (TNDM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-131.9%FY2025 · since FY2018: -93.4% → -131.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -131.9% | -95.4 pp |
| FY2024 | -36.5% | +34.5 pp |
| FY2023 | -71.0% | -49.5 pp |
| FY2022 | -21.5% | -25.1 pp |
| FY2021 | 3.6% | +13.0 pp |
| FY2020 | -9.4% | +3.3 pp |
| FY2019 | -12.7% | +80.7 pp |
| FY2018 | -93.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice